Trademark: 86584777
Word
EKOS RESOLVE
Status
Pending
Status Code
730
Status Date
Friday, September 23, 2016
Serial Number
86584777
Mark Type
4000
Filing Date
Wednesday, April 1, 2015
Published for Opposition
Tuesday, November 3, 2015

Trademark Owner History
EKOS Corporation - Owner At Publication

Classifications
5 Pharmaceutical and medicinal preparations and substances for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; Pharmaceutical and medicinal preparations and substances, namely, lysing solutions and reagents, and hemolytic lysing solutions and reagents; chemical reagents for medical therapeutic purposes; chemico-pharmaceutical preparations for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs
10 Surgical apparatus and instruments; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and software sold as a unit therewith; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus; Drug delivery apparatus and instruments, namely, ultrasonic medical apparatus and software sold as a unit therewith; Drug delivery systems; surgical and medical apparatus and instruments for use in treatment of the circulatory system; Medical apparatus and instruments for use in the prevention and treatment of the circulatory system issues and conditions, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; medical devices which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers and power units therefor; catheters; parts and fittings for all the aforesaid goods
41 Education services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; training in the use and operation of medical devices, medical ultrasound apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; educational services, namely, providing non-downloadable webinars in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; providing computer, electronic and on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; advisory services in the fields of medical education; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; educational services, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and distribution of course material in connection therewith; non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; electronic on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine

Trademark Events
Sep 27, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 23, 2016
Extension 1 Granted
Sep 23, 2016
Extension 1 Filed
Sep 23, 2016
Teas Extension Received
Apr 12, 2016
Noa E-Mailed - Sou Required From Applicant
Mar 2, 2016
Ttab Release Case To Trademarks
Feb 22, 2016
Extension Of Time To Oppose Process - Terminated
Feb 3, 2016
Changes/Corrections After Pub Approval Entered
Feb 3, 2016
Assigned To Petition Staff
Jan 15, 2016
Teas Post Publication Amendment Received
Nov 30, 2015
Extension Of Time To Oppose Received
Nov 3, 2015
Official Gazette Publication Confirmation E-Mailed
Nov 3, 2015
Published For Opposition
Oct 14, 2015
Notification Of Notice Of Publication E-Mailed
Sep 28, 2015
Law Office Publication Review Completed
Sep 18, 2015
Approved For Pub - Principal Register
Sep 16, 2015
Teas/Email Correspondence Entered
Sep 16, 2015
Correspondence Received In Law Office
Sep 10, 2015
Teas Response To Suspension Inquiry Received
Jul 15, 2015
Notification Of Letter Of Suspension E-Mailed
Jul 15, 2015
Letter Of Suspension E-Mailed
Jul 15, 2015
Suspension Letter Written
Jul 8, 2015
Applicant Amendment Prior To Examination - Entered
Jul 8, 2015
Assigned To Examiner
Jul 7, 2015
Assigned To Lie
Jun 30, 2015
Assigned To Lie
Jun 19, 2015
Assigned To Lie
Jun 11, 2015
Teas Voluntary Amendment Received
Apr 11, 2015
New Application Office Supplied Data Entered In Tram
Apr 4, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24